![](https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2022/05/25/abtech_13.png)
- Needham analyst Scott Berg maintained WalkMe Ltd (NASDAQ:WKME) with a Buy and lowered the price target from $40 to $20 (132.3% upside) post Q1 FY22 results.
- Berg attended WalkMe's first Analyst Day, becoming more optimistic about its value proposition and ability to become a more strategic partner with customers.
- Also Read: Here's How KeyBanc Rates WalkMe Post Q1 Results
- Key takeaways include 1) WKME's expanding ability to move from a single-use application to a more broadly used platform. 2) Ramping GTM investments can deliver the 30% annual growth profile management has conveyed since its IPO. 3) Expansion within its current customer base could alone deliver its growth goals with a significant upsell opportunity. 4) A Financial profile that emphasizes a 30% revenue growth profile over the near term but exhibits typical SaaS profitability at scale with 20% or better operating margins.
- He saw the current valuation at less than 2x its FY23 revenue estimate as attractive if the company could deliver its 30% growth goal.
- Price Action: WKME shares traded higher by 12.30% at $8.98 on the last check Wednesday.